-
Most Recent
Search Results
240 results for BIOF
Outlook for IBIO Stock Remains Strong as World Seeks Covid Coutermeasures
Plant-based technology could be the key to a vaccine, and IBIO stockholders could benefit as the company develops potential solutions.
iBio Is One of the Top Pandemic Opportunities
With iBio’s FastPharming technology and its vaccines in the works, IBIO stock is well worth gambling on at its current prices.
Why Bank of America Corp (BAC) Stock Is the Hottest Ticket in Town
Bank of America stock has been plagued with questions, but all of the questions for BAC went away with the surprise election of Donald Trump.
BHTG Stock: The Carnival Deal That Has BioHiTech Global Cruising Higher Today
BioHiTech Global (BHTG) stock is up on Thursday after the waste management company announced a $1.8 million deal with Carnival (CCL).
I Was So Wrong on Bank of America
This writer admits he was dead wrong on the solvency of BofA. It’s in fine shape and his primary concerns have turned out to be…
BioRestorative Therapeutics (BRTX) Stock Soars 40% on Patent News
Could more patents translate to more revenue for BioRestorative Therapeutics? It’s a question that BRTX stock traders are considering now.
Inside Bank of America’s Mixed Bag
What should investors make of Bank of America’s third-quarter report? While it’s OK overall, there are some caveats once you take a closer look.
Why Is Biora Therapeutics (BIOR) Stock Up 12% Today?
Biora Therapeutics (BIOR) stock is on the rise Wednesday following news of feedback from the U.S. Food and Drug Administration (FDA).
Why Is BioSig Technologies (BSGM) Stock Up 19% Today?
BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia’s (NVDA) Inception program.
Biotech Movers: A Doubler for Opexa
A good week for little guys Opexa Therapeutics and Hyperion Therapeutics and giant Biogen. But Hemispherx BioPharma and BioCryst Pharmaceuticals had downers.
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
BIO stock results show that Bio-Rad Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Why iBio Stock Could Soar 500% Above Its Current Levels
IBIO stock is backed by promising technology in its efforts to make a coronavirus vaccine and a well-connected partner.
There Simply Isn’t Enough Good News for iBio
IBIO stock has faded from its highs with good reason: the company isn’t giving investors enough reason to jump in.
I’m Recommending Canopy Growth Stock… but Not for the Reason You Think
Owning CGC stock is a legalized-cannabis play, of course – but could it also be a sports-nutrition play?
3 Pros, 3 Cons For Buying iBio Stock Right Now
IBIO stock has drawn a good deal of interest of late. It’s a speculative play with the potential to reward optimistic investors handsomely.
iBio Remains a Biotech Sideline Play as Covid Rages
Investor interest a unique production system isn’t enough to make buying IBIO stock a worthwhile move at this time.
Riot Platforms Is Betting Big on Bitfarms (BITF) Stock… What Comes Next?
Riot Platforms (RIOT) is in focus on Bitfarms news. BTC miners use large amounts of energy and consolidation is seen as a way to generate…
IBIO Stock Is a Unique and Worthy Biotech Bet
IBIO stock looks like a worthy wager on exciting plant-based solutions. Here’s what prospective investors need to consider before buying.
iBio Is a Wishful Thinkers Coronavirus Vaccine Bet
IBIO stock isn’t the coronavirus vaccine bet investors should pursue, with its candidates in pre-clinical stages showing minimal promise.
Without a Partner, iBio’s Gains Are Just a Fantasy
iBio is behind others in developing a Covid-19 vaccine and it doesn’t have a FastPharming partner. There’s diminishing value to IBIO stock.
BioNano Genomics Is About the Future, Not the Present
BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.
9 – 10 of 240 results
